|
US3958002A
(en)
|
1972-06-20 |
1976-05-18 |
Pierre Fabre S.A. |
Medicaments having psychotropic properties (antitussives)
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
GB9518953D0
(en)
|
1995-09-15 |
1995-11-15 |
Pfizer Ltd |
Pharmaceutical formulations
|
|
WO2000035298A1
(en)
|
1996-11-27 |
2000-06-22 |
Wm. Wrigley Jr. Company |
Chewing gum containing medicament active agents
|
|
GB9711643D0
(en)
|
1997-06-05 |
1997-07-30 |
Janssen Pharmaceutica Nv |
Glass thermoplastic systems
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
EP1636207A1
(en)
*
|
2003-06-12 |
2006-03-22 |
Novo Nordisk A/S |
Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
|
|
US7417063B2
(en)
|
2004-04-13 |
2008-08-26 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles useful as serine protease inhibitors
|
|
JP4842929B2
(ja)
|
2004-05-27 |
2011-12-21 |
ファイザー・プロダクツ・インク |
癌治療に有用なピロロピリミジン誘導体
|
|
US20070275968A1
(en)
|
2004-09-07 |
2007-11-29 |
Hitoshi Kurata |
Substituted Biphenyl Derivative
|
|
US8071768B2
(en)
*
|
2005-06-10 |
2011-12-06 |
Janssen Pharmaceutica, N.V. |
Alkylquinoline and alkylquinazoline kinase modulators
|
|
US7405302B2
(en)
|
2005-10-11 |
2008-07-29 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
GB0526107D0
(en)
|
2005-12-22 |
2006-02-01 |
Angeletti P Ist Richerche Bio |
Therapeutic Compounds
|
|
RU2323058C1
(ru)
|
2006-07-12 |
2008-04-27 |
ООО Научно-внедренческий центр "Машины и оборудование для энергетики" |
Способ формирования наружной резьбы на концевом участке трубной заготовки
|
|
JPWO2008023720A1
(ja)
*
|
2006-08-23 |
2010-01-14 |
アステラス製薬株式会社 |
ウレア化合物又はその塩
|
|
RU2009122670A
(ru)
|
2006-12-21 |
2011-01-27 |
Плекссикон, Инк. (Us) |
Соединения и способы для модуляции киназ и показания к их применению
|
|
CL2008000835A1
(es)
|
2007-03-23 |
2008-10-03 |
Icagen Inc Pfizer Ltd |
Compuestos derivados de sulfonamidas, inhibidores de los canales de calcio; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, sindrome de intestino irritable, enfermedad de crohn, taquiarritm
|
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン,インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
|
US8158636B2
(en)
|
2008-05-19 |
2012-04-17 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
|
US8110576B2
(en)
|
2008-06-10 |
2012-02-07 |
Plexxikon Inc. |
Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
|
|
CN104530052A
(zh)
|
2008-06-10 |
2015-04-22 |
普莱希科公司 |
用于激酶调节的5h-吡咯[2,3-b]吡嗪衍生物和其适应症
|
|
CA2747419C
(en)
|
2009-01-12 |
2014-07-08 |
Icagen, Inc. |
Sulfonamide derivatives
|
|
CN102438991B
(zh)
|
2009-04-29 |
2015-08-26 |
兴和株式会社 |
具有杂环连接基的甲醇化合物
|
|
WO2011021645A1
(ja)
*
|
2009-08-19 |
2011-02-24 |
大日本住友製薬株式会社 |
2環性ウレア誘導体、またはその薬学的に許容される塩
|
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
|
EP2694509B1
(en)
|
2011-04-05 |
2016-05-18 |
Pfizer Limited |
Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of tropomyosin-related kinases
|
|
NZ618795A
(en)
|
2011-05-13 |
2015-07-31 |
Array Biopharma Inc |
Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitors
|
|
JP2014520879A
(ja)
|
2011-07-15 |
2014-08-25 |
ファイザー・インク |
Gpr119調節因子
|
|
KR20140105508A
(ko)
|
2011-12-12 |
2014-09-01 |
닥터 레디스 레보러터리즈 리미티드 |
트로포미오신 수용체 키나제(Trk) 억제제인 치환된 피라졸로[1,5-a]피리딘
|
|
ES2605388T3
(es)
|
2012-04-26 |
2017-03-14 |
Ono Pharmaceutical Co., Ltd. |
Compuesto inhibidor de Trk
|